CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Rosenbaum David P. Chief Development Officer | Sale | −4,941 | $4.79 | $24K | 297,005 |
| 2024-11-20 | Rosenbaum David P. Chief Development Officer | Sale | −2,243 | $4.79 | $11K | 151,373 |
| 2024-11-06 | Rosenbaum David P. Chief Development Officer | Exercise or conversion | +27,171 | $2.32 | $63K | 180,787 |
| 2024-11-06 | Rosenbaum David P. Chief Development Officer | Sale | −27,171 | $6.10 | $166K | 153,616 |
| 2024-11-06 | Rosenbaum David P. Chief Development Officer | Exercise or conversion · Stock Option (Right to Buy) | −27,171 | 0 | ||
| 2024-11-04 | Rosenbaum David P. Chief Development Officer | Exercise or conversion | +27,172 | $2.32 | $63K | 180,788 |
| 2024-11-04 | Rosenbaum David P. Chief Development Officer | Sale | −27,172 | $5.95 | $162K | 153,616 |
| 2024-11-04 | Rosenbaum David P. Chief Development Officer | Exercise or conversion · Stock Option (Right to Buy) | −27,172 | $2.32 | $63K | 27,171 |
| 2024-09-27 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −49,564 | $6.92 | $343K | 301,946 |
| 2024-09-13 | Rosenbaum David P. Chief Development Officer | Sale | −5,312 | $6.26 | $33K | 153,616 |
| 2024-08-20 | Rosenbaum David P. Chief Development Officer | Sale | −4,969 | $5.86 | $29K | 351,510 |
| 2024-08-20 | Rosenbaum David P. Chief Development Officer | Sale | −2,250 | $5.86 | $13K | 156,252 |
| 2024-08-20 | Rosenbaum David P. Chief Development Officer | Exercise or conversion 10b5-1 | +20,507 | $0.99 | $20K | 179,009 |
| 2024-08-20 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −20,507 | $6.00 | $123K | 158,502 |
| 2024-08-20 | Rosenbaum David P. Chief Development Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −20,507 | 49,806 | ||
| 2024-08-16 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −20,000 | $5.94 | $119K | 356,479 |
| 2024-06-03 | Rosenbaum David P. Chief Development Officer | Sale | −17,872 | $7.00 | $125K | 158,502 |
| 2024-05-21 | Rosenbaum David P. Chief Development Officer | Sale | −4,855 | $7.81 | $38K | 376,479 |
| 2024-05-21 | Rosenbaum David P. Chief Development Officer | Sale | −2,198 | $7.81 | $17K | 176,374 |
| 2024-02-26 | Rosenbaum David P. Chief Development Officer | Sale | −5,183 | $9.20 | $48K | 175,936 |
Page 1 of 4 · 74 trades